Expanding Prenatal Screening for Antiphospholipid Syndrome: A Bipartisan Resolution in Response to Christina Perri's Advocacy

Rep. Kat Cammack and Rep. Sydney Kamlager-Dove are set to introduce a bipartisan resolution aimed at expanding prenatal screening for Antiphospholipid Syndrome (APS), a blood clotting disorder that can lead to pregnancy complications. The resolution is a response to the advocacy of Christina Perri, a well-known singer-songwriter who lost her daughter due to undiagnosed APS and is now working to raise awareness about the condition.
Christina Perri, famous for her song "A Thousand Years," has been actively involved in promoting prenatal screening for APS following her personal experience with pregnancy loss. After losing her daughter Rosie and being diagnosed with APS, Perri has been advocating for early detection of the condition, which can be managed with blood thinners if identified in time.
Antiphospholipid Syndrome (APS) is a treatable blood clotting disorder that is associated with miscarriages, stillbirths, and other pregnancy complications. Early detection of APS through prenatal screening can help prevent adverse outcomes and enable timely management of the condition with simple interventions like blood thinners.
The bipartisan resolution introduced by Rep. Kat Cammack and Rep. Sydney Kamlager-Dove aims to expand access to prenatal screening for APS, with the goal of improving outcomes for pregnant individuals at risk of the condition. By raising awareness about APS and advocating for early detection, the resolution seeks to prevent tragedies like the loss experienced by Christina Perri and other families affected by undiagnosed APS.
In conclusion, the collaborative efforts of Rep. Kat Cammack, Rep. Sydney Kamlager-Dove, and Christina Perri highlight the importance of expanding prenatal screening for Antiphospholipid Syndrome. By working together to raise awareness and promote early detection of APS, they aim to improve outcomes for pregnant individuals and prevent the devastating consequences of undiagnosed APS during pregnancy.